SCHEMBL30906456

CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)[C@@H](C)O

nearest known ligand 0.67

Predicted protein targets (top 13)

	gene	UniProt	supporting neighbours	confidence
▸	NPY1R	P25929	1/20	0.67

▸	NPY2R	P49146	1/20	0.67

▸	NPY4R	P50391	1/20	0.67

▸	NPY5R	Q15761	1/20	0.67

▸	IL23R	Q5VWK5	1/20	0.65

▸	GLP1R	P43220	8/20	0.64

▸	CXCR4	P61073	3/20	0.62

▸	CALCR	P30988	4/20	0.61

▸	ECE1	P42892	1/20	0.61

▸	MUS81	Q96NY9	1/20	0.61

▸	CCKBR	P32239	2/20	0.60

▸	EP300	Q09472	1/20	0.60

▸	HIF1A	Q16665	1/20	0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30906481	0.98	GLP1R (0.64)	NPY1RNPY2RNPY4RNPY5RIL23R
SCHEMBL30906425	0.98	GLP1R (0.64)	NPY1RNPY2RNPY4RNPY5RIL23R
SCHEMBL30906379	0.96	NPY1R (0.66)	NPY1RNPY2RNPY4RNPY5RIL23R
SCHEMBL30906365	0.92	GLP1R (0.63)	NPY1RNPY2RNPY4RNPY5RIL23R
SCHEMBL31000901	0.92	GLP1R (0.63)	NPY1RNPY2RNPY4RNPY5RIL23R
SCHEMBL30906446	0.92	GLP1R (0.63)	NPY1RNPY2RNPY4RNPY5RIL23R
SCHEMBL30906341	0.92	GLP1R (0.63)	NPY1RNPY2RNPY4RNPY5RIL23R
SCHEMBL30906374	0.92	GLP1R (0.63)	NPY1RNPY2RNPY4RNPY5RIL23R
SCHEMBL30906550	0.91	GLP1R (0.61)	NPY1RNPY2RNPY4RNPY5RIL23R
SCHEMBL30669427	0.91	NPY2R (0.69)	NPY1RNPY2RNPY4RNPY5RIL23R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed